ARKK vs ARKG: Holdings Overlap
ARK · 45 holdings · $6.0B · as of 2026-04-30
ARKGARK Genomic Revolution ETF
ARK · 32 holdings · $1.6B · as of 2026-04-30
How similar are ARKK and ARKG?
ARK Innovation ETF (ARKK, by ARK) holds 45 positions; ARK Genomic Revolution ETF (ARKG, by ARK) holds 32. They have 13 holdings in common, and by portfolio weight the two funds are 26.7% identical. In practical terms the pair is lightly overlapping, with most of each portfolio distinct.
- Overlap by Weight
- 26.7%Sum of the smaller weight of each shared holding
- Shared Holdings
- 13ARKK holds 45 · ARKG holds 32
- Weight in Shared Holdings
- ARKK 27%·ARKG 61%Share of each fund's weight in stocks both funds own
Based on each fund's latest official holdings. How is this calculated?
What makes each fund different
Only in ARKK
32 of 45 positions (73.3% of the fund) are not held by ARKG. Showing the top 30 by weight.
Sector Breakdown
| Sector | ARKK | ARKG |
|---|---|---|
| Health Care | 26.7% | 93.3% |
| Information Technology | 26.0% | 0.0% |
| Financials | 16.8% | 0.0% |
| Consumer Discretionary | 13.3% | 0.0% |
| Communication Services | 10.5% | 0.0% |
| Other Sectors | 4.8% | 0.0% |
| Unclassified | 1.8% | 6.3% |
Share of each fund's portfolio weight by GICS-style sector, compiled from issuer fund data and our own classification of the holdings, not the issuers' published sector charts. “Unclassified” is weight we could not classify (2% of ARKK, 6% of ARKG).
Performance
| Fund | 1M | YTD | 1Y | 3Y (ann.) | 5Y (ann.) | 10Y (ann.) |
|---|---|---|---|---|---|---|
| ARKK | -2.2% | +3.3% | +6.8% | +21.1% | -8.1% | +15.3% |
| ARKG | +1.0% | +48.6% | +84.8% | +9.2% | -13.0% | +9.2% |
Total returns including dividends, from adjusted daily closes as of 2026-08-07. 3Y/5Y/10Y are annualized. Past performance does not predict future results.
Project the growth of $10,000 in ARKK vs ARKG →
Shared Holdings(13)
The top 10 shared positions account for 95% of the overlap, led by TEM, 1CG and BEAM.
 TEMTempus AI, Inc., Class A | 5.36% | 9.42% | 5.36% |
|---|---|---|---|
 1CGCRISPR Therapeutics AG COM CHF0.03 | 4.98% | 8.91% | 4.98% |
 BEAMBeam Therapeutics Inc. COM | 3.06% | 5.43% | 3.06% |
 TWSTTwist Bioscience Corporation COM | 3.05% | 8.99% | 3.05% |
 TXG10X Genomics, Inc., Class A | 2.31% | 5.77% | 2.31% |
 NTLAIntellia Therapeutics Inc COM | 2.06% | 3.82% | 2.06% |
 ILMNIllumina Inc COM | 1.20% | 4.03% | 1.20% |
 NTRANatera Inc. COM | 1.17% | 4.07% | 1.17% |
 RXRXRecursion Pharmaceuticals, Inc., Class A | 1.16% | 3.51% | 1.16% |
 VCYTVeracyte Inc COM | 0.89% | 2.66% | 0.89% |
 WGSGeneDx Holdings Corp., Class A | 0.81% | 2.04% | 0.81% |
 PACBPacific Biosciences Of California Inc. COM | 0.36% | 1.41% | 0.36% |
 CERSCerus Corp COM | 0.30% | 1.22% | 0.30% |
Frequently Asked Questions
How much do ARKK and ARKG overlap?
ARKK and ARKG overlap by 26.7% of portfolio weight. They share 13 holdings (ARKK holds 45 positions and ARKG holds 32), based on each fund's latest SEC-reported holdings.
Is it redundant to own both ARKK and ARKG?
The two portfolios are 26.7% identical by weight. Owning both is not redundant. Most of each portfolio is distinct, so the funds can serve different roles.
What are the biggest shared holdings of ARKK and ARKG?
The largest positions held by both funds are TEM, 1CG, BEAM, TWST and TXG. Together the top 10 shared positions account for 95% of the total overlap.
What does ARKK own that ARKG doesn't?
32 positions (73.3% of ARKK) are unique to ARKK, led by TSLA, AMD and SHOP. In the other direction, 19 positions (38.3% of ARKG) are unique to ARKG.